FEED vs REGN · rev $2.6M vs P/E 14, rev $14.34B
ENvue Medical Inc. (FEED) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
ENvue Medical Inc. (FEED) is a medical devices company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported FEED revenue for 2025-12-31 was $2.6M. Net income was -$18.2M. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. FEED currently screens at market cap $4.7M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
FEED currently screens at market cap $4.7M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the FEED and REGN stock pages for the full models.
Not investment advice.